nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—ABCB1—Topotecan—cervical cancer	0.0732	0.625	CbGbCtD
Quetiapine—CHRM3—ureter—cervical cancer	0.0455	0.14	CbGeAlD
Quetiapine—CYP3A4—Topotecan—cervical cancer	0.0439	0.375	CbGbCtD
Quetiapine—H1F0—semen—cervical cancer	0.0327	0.1	CbGeAlD
Quetiapine—CHRM3—exocrine gland—cervical cancer	0.00897	0.0275	CbGeAlD
Quetiapine—Pelvic pain—Topotecan—cervical cancer	0.00876	0.0441	CcSEcCtD
Quetiapine—Intestinal obstruction—Topotecan—cervical cancer	0.00782	0.0393	CcSEcCtD
Quetiapine—Neuralgia—Topotecan—cervical cancer	0.00767	0.0386	CcSEcCtD
Quetiapine—CHRM5—epithelium—cervical cancer	0.00698	0.0214	CbGeAlD
Quetiapine—HTR1E—female gonad—cervical cancer	0.00689	0.0211	CbGeAlD
Quetiapine—ADRA1D—epithelium—cervical cancer	0.00624	0.0191	CbGeAlD
Quetiapine—H1F0—uterine cervix—cervical cancer	0.00597	0.0183	CbGeAlD
Quetiapine—ADRA1B—renal system—cervical cancer	0.00592	0.0182	CbGeAlD
Quetiapine—Dysmenorrhoea—Topotecan—cervical cancer	0.00586	0.0295	CcSEcCtD
Quetiapine—DRD5—female reproductive system—cervical cancer	0.00578	0.0177	CbGeAlD
Quetiapine—H1F0—decidua—cervical cancer	0.00569	0.0175	CbGeAlD
Quetiapine—H1F0—renal system—cervical cancer	0.00559	0.0171	CbGeAlD
Quetiapine—Bone pain—Topotecan—cervical cancer	0.00556	0.028	CcSEcCtD
Quetiapine—H1F0—endometrium—cervical cancer	0.0054	0.0166	CbGeAlD
Quetiapine—Pulmonary embolism—Topotecan—cervical cancer	0.00533	0.0268	CcSEcCtD
Quetiapine—DRD5—female gonad—cervical cancer	0.00526	0.0161	CbGeAlD
Quetiapine—H1F0—mammalian vulva—cervical cancer	0.00522	0.016	CbGeAlD
Quetiapine—H1F0—uterus—cervical cancer	0.00498	0.0153	CbGeAlD
Quetiapine—Rash maculo-papular—Topotecan—cervical cancer	0.00484	0.0244	CcSEcCtD
Quetiapine—Neoplasm—Topotecan—cervical cancer	0.00482	0.0242	CcSEcCtD
Quetiapine—ADRA1D—female reproductive system—cervical cancer	0.00464	0.0142	CbGeAlD
Quetiapine—Ear pain—Topotecan—cervical cancer	0.00454	0.0228	CcSEcCtD
Quetiapine—H1F0—female reproductive system—cervical cancer	0.00447	0.0137	CbGeAlD
Quetiapine—H1F0—female gonad—cervical cancer	0.00407	0.0125	CbGeAlD
Quetiapine—H1F0—vagina—cervical cancer	0.00405	0.0124	CbGeAlD
Quetiapine—Lethargy—Topotecan—cervical cancer	0.00395	0.0199	CcSEcCtD
Quetiapine—HTR7—epithelium—cervical cancer	0.00372	0.0114	CbGeAlD
Quetiapine—Cardiac arrest—Topotecan—cervical cancer	0.00368	0.0185	CcSEcCtD
Quetiapine—CHRM3—renal system—cervical cancer	0.00362	0.0111	CbGeAlD
Quetiapine—HTR1A—renal system—cervical cancer	0.00361	0.0111	CbGeAlD
Quetiapine—ADRA1A—epithelium—cervical cancer	0.00358	0.011	CbGeAlD
Quetiapine—HTR1B—female reproductive system—cervical cancer	0.00358	0.011	CbGeAlD
Quetiapine—Cramp muscle—Topotecan—cervical cancer	0.00348	0.0175	CcSEcCtD
Quetiapine—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.00348	0.0175	CcSEcCtD
Quetiapine—HTR1D—female reproductive system—cervical cancer	0.00347	0.0106	CbGeAlD
Quetiapine—HTR7—renal system—cervical cancer	0.00345	0.0106	CbGeAlD
Quetiapine—HTR2C—female reproductive system—cervical cancer	0.00343	0.0105	CbGeAlD
Quetiapine—Alanine aminotransferase increased—Topotecan—cervical cancer	0.00341	0.0172	CcSEcCtD
Quetiapine—ADRA2C—uterine cervix—cervical cancer	0.00339	0.0104	CbGeAlD
Quetiapine—ADRA1A—renal system—cervical cancer	0.00332	0.0102	CbGeAlD
Quetiapine—CHRM1—female reproductive system—cervical cancer	0.00324	0.00994	CbGeAlD
Quetiapine—ADRA2C—decidua—cervical cancer	0.00323	0.0099	CbGeAlD
Quetiapine—ADRA2C—renal system—cervical cancer	0.00317	0.00972	CbGeAlD
Quetiapine—Neutropenia—Topotecan—cervical cancer	0.00313	0.0157	CcSEcCtD
Quetiapine—ADRA2C—endometrium—cervical cancer	0.00306	0.0094	CbGeAlD
Quetiapine—Weight increased—Topotecan—cervical cancer	0.00304	0.0153	CcSEcCtD
Quetiapine—Pneumonia—Topotecan—cervical cancer	0.003	0.0151	CcSEcCtD
Quetiapine—Infestation NOS—Topotecan—cervical cancer	0.00298	0.015	CcSEcCtD
Quetiapine—Infestation—Topotecan—cervical cancer	0.00298	0.015	CcSEcCtD
Quetiapine—ADRA2C—mammalian vulva—cervical cancer	0.00296	0.00909	CbGeAlD
Quetiapine—Stomatitis—Topotecan—cervical cancer	0.00291	0.0146	CcSEcCtD
Quetiapine—CHRM3—female reproductive system—cervical cancer	0.0029	0.0089	CbGeAlD
Quetiapine—Sweating—Topotecan—cervical cancer	0.00286	0.0144	CcSEcCtD
Quetiapine—CYP3A5—uterine cervix—cervical cancer	0.00283	0.0087	CbGeAlD
Quetiapine—ADRA2C—uterus—cervical cancer	0.00282	0.00866	CbGeAlD
Quetiapine—Hepatobiliary disease—Topotecan—cervical cancer	0.00282	0.0142	CcSEcCtD
Quetiapine—Epistaxis—Topotecan—cervical cancer	0.00281	0.0141	CcSEcCtD
Quetiapine—HRH1—epithelium—cervical cancer	0.00277	0.00851	CbGeAlD
Quetiapine—HTR7—female reproductive system—cervical cancer	0.00276	0.00847	CbGeAlD
Quetiapine—HRH1—uterine cervix—cervical cancer	0.00275	0.00844	CbGeAlD
Quetiapine—ADRA2A—uterine cervix—cervical cancer	0.0027	0.00829	CbGeAlD
Quetiapine—Haemoglobin—Topotecan—cervical cancer	0.00269	0.0135	CcSEcCtD
Quetiapine—Rhinitis—Topotecan—cervical cancer	0.00268	0.0135	CcSEcCtD
Quetiapine—Haemorrhage—Topotecan—cervical cancer	0.00268	0.0135	CcSEcCtD
Quetiapine—Hypoaesthesia—Topotecan—cervical cancer	0.00266	0.0134	CcSEcCtD
Quetiapine—Pharyngitis—Topotecan—cervical cancer	0.00266	0.0134	CcSEcCtD
Quetiapine—CYP3A5—renal system—cervical cancer	0.00265	0.00813	CbGeAlD
Quetiapine—CHRM3—female gonad—cervical cancer	0.00264	0.0081	CbGeAlD
Quetiapine—HRH1—decidua—cervical cancer	0.00262	0.00804	CbGeAlD
Quetiapine—H1F0—lymph node—cervical cancer	0.00262	0.00803	CbGeAlD
Quetiapine—ADRA2A—decidua—cervical cancer	0.00257	0.0079	CbGeAlD
Quetiapine—HRH1—endometrium—cervical cancer	0.00249	0.00763	CbGeAlD
Quetiapine—ADRA2A—endometrium—cervical cancer	0.00244	0.0075	CbGeAlD
Quetiapine—CYP2C19—vagina—cervical cancer	0.00244	0.00748	CbGeAlD
Quetiapine—Angiopathy—Topotecan—cervical cancer	0.00243	0.0122	CcSEcCtD
Quetiapine—Immune system disorder—Topotecan—cervical cancer	0.00242	0.0122	CcSEcCtD
Quetiapine—Mediastinal disorder—Topotecan—cervical cancer	0.00241	0.0121	CcSEcCtD
Quetiapine—HRH1—mammalian vulva—cervical cancer	0.00241	0.00738	CbGeAlD
Quetiapine—Chills—Topotecan—cervical cancer	0.0024	0.0121	CcSEcCtD
Quetiapine—ADRA2A—mammalian vulva—cervical cancer	0.00236	0.00725	CbGeAlD
Quetiapine—Malnutrition—Topotecan—cervical cancer	0.00233	0.0117	CcSEcCtD
Quetiapine—HTR2A—epithelium—cervical cancer	0.00232	0.00711	CbGeAlD
Quetiapine—ADRA2C—female gonad—cervical cancer	0.00231	0.00708	CbGeAlD
Quetiapine—ADRA2C—vagina—cervical cancer	0.00229	0.00704	CbGeAlD
Quetiapine—Back pain—Topotecan—cervical cancer	0.00225	0.0113	CcSEcCtD
Quetiapine—ADRA2A—uterus—cervical cancer	0.00225	0.00691	CbGeAlD
Quetiapine—Muscle spasms—Topotecan—cervical cancer	0.00224	0.0113	CcSEcCtD
Quetiapine—Ill-defined disorder—Topotecan—cervical cancer	0.00216	0.0109	CcSEcCtD
Quetiapine—Anaemia—Topotecan—cervical cancer	0.00215	0.0108	CcSEcCtD
Quetiapine—HTR2A—renal system—cervical cancer	0.00215	0.00659	CbGeAlD
Quetiapine—Angioedema—Topotecan—cervical cancer	0.00213	0.0107	CcSEcCtD
Quetiapine—Malaise—Topotecan—cervical cancer	0.0021	0.0106	CcSEcCtD
Quetiapine—Leukopenia—Topotecan—cervical cancer	0.00209	0.0105	CcSEcCtD
Quetiapine—HRH1—female reproductive system—cervical cancer	0.00206	0.00632	CbGeAlD
Quetiapine—Cough—Topotecan—cervical cancer	0.00203	0.0102	CcSEcCtD
Quetiapine—ADRA2A—female reproductive system—cervical cancer	0.00202	0.00621	CbGeAlD
Quetiapine—CYP3A4—renal system—cervical cancer	0.00199	0.0061	CbGeAlD
Quetiapine—Arthralgia—Topotecan—cervical cancer	0.00198	0.00997	CcSEcCtD
Quetiapine—Chest pain—Topotecan—cervical cancer	0.00198	0.00997	CcSEcCtD
Quetiapine—Myalgia—Topotecan—cervical cancer	0.00198	0.00997	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00197	0.00991	CcSEcCtD
Quetiapine—Discomfort—Topotecan—cervical cancer	0.00196	0.00986	CcSEcCtD
Quetiapine—CYP2D6—renal system—cervical cancer	0.00196	0.00601	CbGeAlD
Quetiapine—CYP3A5—female gonad—cervical cancer	0.00193	0.00593	CbGeAlD
Quetiapine—CYP3A5—vagina—cervical cancer	0.00192	0.00589	CbGeAlD
Quetiapine—Anaphylactic shock—Topotecan—cervical cancer	0.0019	0.00956	CcSEcCtD
Quetiapine—Infection—Topotecan—cervical cancer	0.00189	0.0095	CcSEcCtD
Quetiapine—HRH1—female gonad—cervical cancer	0.00188	0.00575	CbGeAlD
Quetiapine—Nervous system disorder—Topotecan—cervical cancer	0.00187	0.00938	CcSEcCtD
Quetiapine—HRH1—vagina—cervical cancer	0.00186	0.00572	CbGeAlD
Quetiapine—Thrombocytopenia—Topotecan—cervical cancer	0.00186	0.00936	CcSEcCtD
Quetiapine—Skin disorder—Topotecan—cervical cancer	0.00185	0.00929	CcSEcCtD
Quetiapine—ADRA2A—female gonad—cervical cancer	0.00184	0.00565	CbGeAlD
Quetiapine—Hyperhidrosis—Topotecan—cervical cancer	0.00184	0.00924	CcSEcCtD
Quetiapine—ADRA2A—vagina—cervical cancer	0.00183	0.00562	CbGeAlD
Quetiapine—Anorexia—Topotecan—cervical cancer	0.00181	0.00911	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00173	0.00871	CcSEcCtD
Quetiapine—HTR2A—female reproductive system—cervical cancer	0.00172	0.00528	CbGeAlD
Quetiapine—Paraesthesia—Topotecan—cervical cancer	0.00171	0.00859	CcSEcCtD
Quetiapine—Dyspnoea—Topotecan—cervical cancer	0.0017	0.00852	CcSEcCtD
Quetiapine—Dyspepsia—Topotecan—cervical cancer	0.00167	0.00842	CcSEcCtD
Quetiapine—Decreased appetite—Topotecan—cervical cancer	0.00165	0.00831	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Topotecan—cervical cancer	0.00164	0.00826	CcSEcCtD
Quetiapine—Fatigue—Topotecan—cervical cancer	0.00164	0.00824	CcSEcCtD
Quetiapine—Constipation—Topotecan—cervical cancer	0.00163	0.00818	CcSEcCtD
Quetiapine—Pain—Topotecan—cervical cancer	0.00163	0.00818	CcSEcCtD
Quetiapine—CYP3A4—female reproductive system—cervical cancer	0.00159	0.00489	CbGeAlD
Quetiapine—CYP2D6—female reproductive system—cervical cancer	0.00157	0.00481	CbGeAlD
Quetiapine—Feeling abnormal—Topotecan—cervical cancer	0.00157	0.00788	CcSEcCtD
Quetiapine—HTR2A—vagina—cervical cancer	0.00156	0.00478	CbGeAlD
Quetiapine—Gastrointestinal pain—Topotecan—cervical cancer	0.00156	0.00782	CcSEcCtD
Quetiapine—ABCB1—epithelium—cervical cancer	0.00152	0.00466	CbGeAlD
Quetiapine—ABCB1—uterine cervix—cervical cancer	0.00151	0.00462	CbGeAlD
Quetiapine—Body temperature increased—Topotecan—cervical cancer	0.0015	0.00756	CcSEcCtD
Quetiapine—Abdominal pain—Topotecan—cervical cancer	0.0015	0.00756	CcSEcCtD
Quetiapine—ADRA2C—lymph node—cervical cancer	0.00148	0.00455	CbGeAlD
Quetiapine—ABCB1—decidua—cervical cancer	0.00143	0.0044	CbGeAlD
Quetiapine—CYP2D6—female gonad—cervical cancer	0.00143	0.00438	CbGeAlD
Quetiapine—ABCB1—renal system—cervical cancer	0.00141	0.00432	CbGeAlD
Quetiapine—Hypersensitivity—Topotecan—cervical cancer	0.0014	0.00704	CcSEcCtD
Quetiapine—Asthenia—Topotecan—cervical cancer	0.00136	0.00686	CcSEcCtD
Quetiapine—ABCB1—endometrium—cervical cancer	0.00136	0.00418	CbGeAlD
Quetiapine—Pruritus—Topotecan—cervical cancer	0.00135	0.00677	CcSEcCtD
Quetiapine—ABCB1—mammalian vulva—cervical cancer	0.00132	0.00404	CbGeAlD
Quetiapine—Diarrhoea—Topotecan—cervical cancer	0.0013	0.00654	CcSEcCtD
Quetiapine—Dizziness—Topotecan—cervical cancer	0.00126	0.00632	CcSEcCtD
Quetiapine—ABCB1—uterus—cervical cancer	0.00125	0.00385	CbGeAlD
Quetiapine—Vomiting—Topotecan—cervical cancer	0.00121	0.00608	CcSEcCtD
Quetiapine—HRH1—lymph node—cervical cancer	0.00121	0.0037	CbGeAlD
Quetiapine—Rash—Topotecan—cervical cancer	0.0012	0.00603	CcSEcCtD
Quetiapine—Dermatitis—Topotecan—cervical cancer	0.0012	0.00602	CcSEcCtD
Quetiapine—Headache—Topotecan—cervical cancer	0.00119	0.00599	CcSEcCtD
Quetiapine—ADRA2A—lymph node—cervical cancer	0.00118	0.00363	CbGeAlD
Quetiapine—Nausea—Topotecan—cervical cancer	0.00113	0.00568	CcSEcCtD
Quetiapine—ABCB1—female reproductive system—cervical cancer	0.00113	0.00346	CbGeAlD
Quetiapine—ABCB1—female gonad—cervical cancer	0.00103	0.00315	CbGeAlD
Quetiapine—ABCB1—vagina—cervical cancer	0.00102	0.00313	CbGeAlD
Quetiapine—ABCB1—lymph node—cervical cancer	0.00066	0.00202	CbGeAlD
Quetiapine—DRD1—Signaling Pathways—TERT—cervical cancer	6.56e-05	0.000183	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—NOTCH1—cervical cancer	6.56e-05	0.000183	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—MTHFR—cervical cancer	6.55e-05	0.000183	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—NOTCH1—cervical cancer	6.52e-05	0.000182	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TERT—cervical cancer	6.47e-05	0.000181	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TERT—cervical cancer	6.47e-05	0.000181	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—HES1—cervical cancer	6.44e-05	0.00018	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—HES1—cervical cancer	6.41e-05	0.000179	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—CTNNB1—cervical cancer	6.39e-05	0.000178	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—NOTCH1—cervical cancer	6.38e-05	0.000178	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—MTOR—cervical cancer	6.38e-05	0.000178	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—FGFR3—cervical cancer	6.32e-05	0.000176	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—NOTCH1—cervical cancer	6.28e-05	0.000175	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—HES1—cervical cancer	6.23e-05	0.000174	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—NOTCH1—cervical cancer	6.2e-05	0.000173	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	6.17e-05	0.000172	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—HES1—cervical cancer	6.13e-05	0.000171	CbGpPWpGaD
Quetiapine—ADRA2C—Hemostasis—TP53—cervical cancer	6.13e-05	0.000171	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—FGFR3—cervical cancer	6.02e-05	0.000168	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—FGFR3—cervical cancer	5.94e-05	0.000166	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—FGFR3—cervical cancer	5.94e-05	0.000166	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—NOTCH1—cervical cancer	5.93e-05	0.000166	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—CASP3—cervical cancer	5.86e-05	0.000164	CbGpPWpGaD
Quetiapine—HTR6—Signaling by GPCR—EGFR—cervical cancer	5.85e-05	0.000163	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TERT—cervical cancer	5.85e-05	0.000163	CbGpPWpGaD
Quetiapine—HTR7—Signaling by GPCR—EGFR—cervical cancer	5.85e-05	0.000163	CbGpPWpGaD
Quetiapine—HTR1D—Signaling by GPCR—EGFR—cervical cancer	5.81e-05	0.000162	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—MTHFR—cervical cancer	5.8e-05	0.000162	CbGpPWpGaD
Quetiapine—HTR1B—Signaling by GPCR—EGFR—cervical cancer	5.69e-05	0.000159	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—HES1—cervical cancer	5.65e-05	0.000158	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—NOTCH1—cervical cancer	5.65e-05	0.000158	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—CTNNB1—cervical cancer	5.65e-05	0.000158	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TERT—cervical cancer	5.64e-05	0.000158	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TERT—cervical cancer	5.61e-05	0.000157	CbGpPWpGaD
Quetiapine—DRD4—Signaling by GPCR—EGFR—cervical cancer	5.6e-05	0.000156	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CA9—cervical cancer	5.58e-05	0.000156	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—NOTCH1—cervical cancer	5.58e-05	0.000156	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—NOTCH1—cervical cancer	5.58e-05	0.000156	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—STAT3—cervical cancer	5.57e-05	0.000155	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—HES1—cervical cancer	5.56e-05	0.000155	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—HES1—cervical cancer	5.55e-05	0.000155	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—HES1—cervical cancer	5.53e-05	0.000155	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—EGFR—cervical cancer	5.52e-05	0.000154	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—HES1—cervical cancer	5.52e-05	0.000154	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—HES1—cervical cancer	5.46e-05	0.000153	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TERT—cervical cancer	5.46e-05	0.000152	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—HES1—cervical cancer	5.45e-05	0.000152	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TERT—cervical cancer	5.37e-05	0.00015	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—FGFR3—cervical cancer	5.36e-05	0.00015	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—MTHFR—cervical cancer	5.32e-05	0.000149	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—EGFR—cervical cancer	5.29e-05	0.000148	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—FGFR3—cervical cancer	5.18e-05	0.000145	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—FGFR3—cervical cancer	5.15e-05	0.000144	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—HES1—cervical cancer	5.06e-05	0.000141	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—EGFR—cervical cancer	5.06e-05	0.000141	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—EGFR—cervical cancer	5.04e-05	0.000141	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—NOTCH1—cervical cancer	5.04e-05	0.000141	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—FGFR3—cervical cancer	5.01e-05	0.00014	CbGpPWpGaD
Quetiapine—ADRA2A—Hemostasis—TP53—cervical cancer	4.98e-05	0.000139	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—EGFR—cervical cancer	4.97e-05	0.000139	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—EGFR—cervical cancer	4.97e-05	0.000139	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TERT—cervical cancer	4.95e-05	0.000138	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—FGFR3—cervical cancer	4.93e-05	0.000138	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—STAT3—cervical cancer	4.93e-05	0.000138	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—MTOR—cervical cancer	4.92e-05	0.000137	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—MTOR—cervical cancer	4.92e-05	0.000137	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—MTOR—cervical cancer	4.88e-05	0.000136	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TERT—cervical cancer	4.87e-05	0.000136	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—MTHFR—cervical cancer	4.87e-05	0.000136	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TERT—cervical cancer	4.86e-05	0.000136	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	4.86e-05	0.000136	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TERT—cervical cancer	4.85e-05	0.000135	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	4.84e-05	0.000135	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TERT—cervical cancer	4.83e-05	0.000135	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TERT—cervical cancer	4.79e-05	0.000134	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—MTOR—cervical cancer	4.78e-05	0.000134	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TERT—cervical cancer	4.77e-05	0.000133	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—MTOR—cervical cancer	4.71e-05	0.000131	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—NOTCH1—cervical cancer	4.7e-05	0.000131	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—MTOR—cervical cancer	4.64e-05	0.00013	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—NOTCH1—cervical cancer	4.63e-05	0.000129	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—FGFR3—cervical cancer	4.55e-05	0.000127	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—CASP3—cervical cancer	4.53e-05	0.000126	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—CASP3—cervical cancer	4.52e-05	0.000126	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—CASP3—cervical cancer	4.49e-05	0.000125	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—EGFR—cervical cancer	4.49e-05	0.000125	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—EGFR—cervical cancer	4.48e-05	0.000125	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—FGFR3—cervical cancer	4.47e-05	0.000125	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—FGFR3—cervical cancer	4.46e-05	0.000125	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—FGFR3—cervical cancer	4.45e-05	0.000124	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—MTOR—cervical cancer	4.45e-05	0.000124	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—FGFR3—cervical cancer	4.44e-05	0.000124	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TERT—cervical cancer	4.43e-05	0.000124	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—CASP3—cervical cancer	4.4e-05	0.000123	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—FGFR3—cervical cancer	4.39e-05	0.000123	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	4.38e-05	0.000122	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—CTNNB1—cervical cancer	4.36e-05	0.000122	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—CTNNB1—cervical cancer	4.36e-05	0.000122	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—EGFR—cervical cancer	4.33e-05	0.000121	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—CTNNB1—cervical cancer	4.33e-05	0.000121	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—CASP3—cervical cancer	4.33e-05	0.000121	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—EGFR—cervical cancer	4.31e-05	0.00012	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—CASP3—cervical cancer	4.27e-05	0.000119	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—NOTCH1—cervical cancer	4.27e-05	0.000119	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—TP53—cervical cancer	4.25e-05	0.000119	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—CTNNB1—cervical cancer	4.24e-05	0.000118	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—MTOR—cervical cancer	4.24e-05	0.000118	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	4.2e-05	0.000117	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—EGFR—cervical cancer	4.19e-05	0.000117	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—NOTCH1—cervical cancer	4.19e-05	0.000117	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—MTOR—cervical cancer	4.18e-05	0.000117	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—MTOR—cervical cancer	4.18e-05	0.000117	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—NOTCH1—cervical cancer	4.18e-05	0.000117	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—CTNNB1—cervical cancer	4.17e-05	0.000117	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—NOTCH1—cervical cancer	4.16e-05	0.000116	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—EGFR—cervical cancer	4.12e-05	0.000115	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—NOTCH1—cervical cancer	4.12e-05	0.000115	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—CTNNB1—cervical cancer	4.12e-05	0.000115	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	4.11e-05	0.000115	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—CASP3—cervical cancer	4.09e-05	0.000114	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	4.07e-05	0.000114	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—CTNNB1—cervical cancer	3.94e-05	0.00011	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—CASP3—cervical cancer	3.9e-05	0.000109	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—CASP3—cervical cancer	3.84e-05	0.000107	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—CASP3—cervical cancer	3.84e-05	0.000107	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	3.82e-05	0.000107	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—STAT3—cervical cancer	3.8e-05	0.000106	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—EGFR—cervical cancer	3.8e-05	0.000106	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—STAT3—cervical cancer	3.8e-05	0.000106	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—STAT3—cervical cancer	3.77e-05	0.000105	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MTOR—cervical cancer	3.77e-05	0.000105	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—MTHFR—cervical cancer	3.77e-05	0.000105	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—TP53—cervical cancer	3.76e-05	0.000105	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—CTNNB1—cervical cancer	3.76e-05	0.000105	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—EGFR—cervical cancer	3.74e-05	0.000104	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—EGFR—cervical cancer	3.73e-05	0.000104	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—EGFR—cervical cancer	3.72e-05	0.000104	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—EGFR—cervical cancer	3.71e-05	0.000104	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—CTNNB1—cervical cancer	3.71e-05	0.000103	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—CTNNB1—cervical cancer	3.71e-05	0.000103	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—STAT3—cervical cancer	3.7e-05	0.000103	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—MTHFR—cervical cancer	3.68e-05	0.000103	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—EGFR—cervical cancer	3.67e-05	0.000103	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	3.66e-05	0.000102	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MTOR—cervical cancer	3.64e-05	0.000102	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—STAT3—cervical cancer	3.64e-05	0.000102	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MTOR—cervical cancer	3.62e-05	0.000101	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—STAT3—cervical cancer	3.59e-05	0.0001	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MTOR—cervical cancer	3.53e-05	9.84e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—CASP3—cervical cancer	3.47e-05	9.69e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MTOR—cervical cancer	3.47e-05	9.69e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—MTHFR—cervical cancer	3.47e-05	9.68e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—EGFR—cervical cancer	3.46e-05	9.65e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—EGFR—cervical cancer	3.45e-05	9.64e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—STAT3—cervical cancer	3.44e-05	9.59e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—EGFR—cervical cancer	3.43e-05	9.58e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	3.4e-05	9.51e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—EGFR—cervical cancer	3.36e-05	9.38e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CASP3—cervical cancer	3.35e-05	9.36e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—CTNNB1—cervical cancer	3.35e-05	9.34e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CASP3—cervical cancer	3.33e-05	9.31e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—EGFR—cervical cancer	3.31e-05	9.23e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—STAT3—cervical cancer	3.27e-05	9.14e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—EGFR—cervical cancer	3.26e-05	9.11e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CASP3—cervical cancer	3.24e-05	9.05e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—STAT3—cervical cancer	3.23e-05	9.02e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—STAT3—cervical cancer	3.23e-05	9.02e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	3.23e-05	9.02e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	3.21e-05	8.97e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MTOR—cervical cancer	3.2e-05	8.93e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CASP3—cervical cancer	3.19e-05	8.91e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MTOR—cervical cancer	3.15e-05	8.79e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MTOR—cervical cancer	3.14e-05	8.77e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MTOR—cervical cancer	3.13e-05	8.74e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CTNNB1—cervical cancer	3.13e-05	8.73e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—EGFR—cervical cancer	3.12e-05	8.72e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MTOR—cervical cancer	3.12e-05	8.71e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MTOR—cervical cancer	3.09e-05	8.63e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MTOR—cervical cancer	3.08e-05	8.61e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CTNNB1—cervical cancer	3.08e-05	8.59e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—EGFR—cervical cancer	2.98e-05	8.31e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CASP3—cervical cancer	2.94e-05	8.22e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—EGFR—cervical cancer	2.94e-05	8.2e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—EGFR—cervical cancer	2.94e-05	8.2e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—STAT3—cervical cancer	2.92e-05	8.14e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TP53—cervical cancer	2.9e-05	8.1e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TP53—cervical cancer	2.9e-05	8.1e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CASP3—cervical cancer	2.89e-05	8.08e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CASP3—cervical cancer	2.89e-05	8.07e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TP53—cervical cancer	2.88e-05	8.04e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CASP3—cervical cancer	2.88e-05	8.04e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CASP3—cervical cancer	2.87e-05	8.01e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MTOR—cervical cancer	2.86e-05	8e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CASP3—cervical cancer	2.84e-05	7.94e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CTNNB1—cervical cancer	2.84e-05	7.92e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CASP3—cervical cancer	2.83e-05	7.92e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TP53—cervical cancer	2.82e-05	7.88e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—STAT3—cervical cancer	2.82e-05	7.86e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—STAT3—cervical cancer	2.8e-05	7.82e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	2.79e-05	7.79e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CTNNB1—cervical cancer	2.78e-05	7.78e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CTNNB1—cervical cancer	2.78e-05	7.75e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TP53—cervical cancer	2.78e-05	7.75e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CTNNB1—cervical cancer	2.77e-05	7.73e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CTNNB1—cervical cancer	2.74e-05	7.65e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TP53—cervical cancer	2.74e-05	7.65e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	2.73e-05	7.63e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—STAT3—cervical cancer	2.72e-05	7.61e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—STAT3—cervical cancer	2.68e-05	7.49e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EGFR—cervical cancer	2.65e-05	7.4e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CASP3—cervical cancer	2.63e-05	7.35e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—cervical cancer	2.62e-05	7.32e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EGFR—cervical cancer	2.56e-05	7.15e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EGFR—cervical cancer	2.55e-05	7.11e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	2.54e-05	7.09e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—cervical cancer	2.5e-05	6.98e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EGFR—cervical cancer	2.48e-05	6.91e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—STAT3—cervical cancer	2.47e-05	6.9e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—cervical cancer	2.47e-05	6.88e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—cervical cancer	2.47e-05	6.88e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EGFR—cervical cancer	2.44e-05	6.8e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—STAT3—cervical cancer	2.43e-05	6.79e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—STAT3—cervical cancer	2.43e-05	6.78e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—STAT3—cervical cancer	2.42e-05	6.76e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—STAT3—cervical cancer	2.41e-05	6.73e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—STAT3—cervical cancer	2.39e-05	6.67e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—STAT3—cervical cancer	2.38e-05	6.65e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—MTHFR—cervical cancer	2.27e-05	6.33e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EGFR—cervical cancer	2.25e-05	6.27e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—cervical cancer	2.23e-05	6.21e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—STAT3—cervical cancer	2.21e-05	6.18e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EGFR—cervical cancer	2.21e-05	6.17e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EGFR—cervical cancer	2.21e-05	6.16e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EGFR—cervical cancer	2.2e-05	6.14e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EGFR—cervical cancer	2.19e-05	6.12e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EGFR—cervical cancer	2.17e-05	6.06e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EGFR—cervical cancer	2.16e-05	6.04e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—cervical cancer	2.15e-05	6e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—cervical cancer	2.14e-05	5.97e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—cervical cancer	2.08e-05	5.81e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—cervical cancer	2.05e-05	5.71e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EGFR—cervical cancer	2.01e-05	5.62e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—cervical cancer	1.89e-05	5.27e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—cervical cancer	1.86e-05	5.18e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—cervical cancer	1.85e-05	5.17e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—cervical cancer	1.85e-05	5.16e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—cervical cancer	1.84e-05	5.14e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—cervical cancer	1.82e-05	5.09e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—cervical cancer	1.82e-05	5.08e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—cervical cancer	1.69e-05	4.72e-05	CbGpPWpGaD
